Biotage AB (publ) (BIOT.ST)
SEK 90.3
(-0.11%)
SEK 90.3
(-0.11%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 437 Million SEK | 43.28% |
| 2022 | 305 Million SEK | 28.69% |
| 2021 | 237 Million SEK | 48.29% |
| 2020 | 159.82 Million SEK | -8.02% |
| 2019 | 173.76 Million SEK | 31.3% |
| 2018 | 132.33 Million SEK | 38.15% |
| 2017 | 95.79 Million SEK | 7.75% |
| 2016 | 88.9 Million SEK | -8.52% |
| 2015 | 97.18 Million SEK | -10.33% |
| 2014 | 108.37 Million SEK | 26.19% |
| 2013 | 85.88 Million SEK | 2.1% |
| 2012 | 84.11 Million SEK | -6.22% |
| 2011 | 89.69 Million SEK | -8.45% |
| 2010 | 97.97 Million SEK | 22.03% |
| 2009 | 80.28 Million SEK | -22.97% |
| 2008 | 104.22 Million SEK | 7.29% |
| 2007 | 97.14 Million SEK | 13.45% |
| 2006 | 85.62 Million SEK | -7.63% |
| 2005 | 92.69 Million SEK | 23.65% |
| 2004 | 74.96 Million SEK | -1.41% |
| 2003 | 76.03 Million SEK | 137.99% |
| 2002 | 31.95 Million SEK | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 475 Million SEK | 7.22% |
| 2024 Q1 | 443 Million SEK | 1.37% |
| 2024 Q3 | 490 Million SEK | 3.16% |
| 2023 Q3 | 508 Million SEK | 16.51% |
| 2023 FY | 437 Million SEK | 43.28% |
| 2023 Q4 | 437 Million SEK | -13.98% |
| 2023 Q2 | 436 Million SEK | 44.37% |
| 2023 Q1 | 302 Million SEK | -0.98% |
| 2022 Q3 | 306 Million SEK | 6.25% |
| 2022 Q4 | 305 Million SEK | -0.33% |
| 2022 Q1 | 244 Million SEK | 2.95% |
| 2022 FY | 305 Million SEK | 28.69% |
| 2022 Q2 | 288 Million SEK | 18.03% |
| 2021 Q3 | 208 Million SEK | 7.04% |
| 2021 FY | 237 Million SEK | 48.29% |
| 2021 Q1 | 191.99 Million SEK | 20.13% |
| 2021 Q2 | 194.32 Million SEK | 1.22% |
| 2021 Q4 | 237 Million SEK | 13.94% |
| 2020 Q3 | 170.6 Million SEK | -3.05% |
| 2020 Q2 | 175.96 Million SEK | -5.39% |
| 2020 FY | 159.82 Million SEK | -8.02% |
| 2020 Q1 | 185.99 Million SEK | 7.04% |
| 2020 Q4 | 159.82 Million SEK | -6.32% |
| 2019 Q2 | 149.58 Million SEK | 0.56% |
| 2019 FY | 173.76 Million SEK | 31.3% |
| 2019 Q4 | 173.76 Million SEK | 1.8% |
| 2019 Q1 | 148.74 Million SEK | 12.4% |
| 2019 Q3 | 170.68 Million SEK | 14.11% |
| 2018 Q1 | 113.28 Million SEK | 18.26% |
| 2018 Q4 | 132.33 Million SEK | 4.84% |
| 2018 FY | 132.33 Million SEK | 38.15% |
| 2018 Q3 | 126.22 Million SEK | 4.94% |
| 2018 Q2 | 120.29 Million SEK | 6.18% |
| 2017 Q1 | 89.54 Million SEK | 0.72% |
| 2017 Q4 | 95.79 Million SEK | 4.16% |
| 2017 Q3 | 91.97 Million SEK | 1.29% |
| 2017 FY | 95.79 Million SEK | 7.75% |
| 2017 Q2 | 90.8 Million SEK | 1.4% |
| 2016 Q4 | 88.9 Million SEK | 0.46% |
| 2016 Q2 | 94.58 Million SEK | 3.17% |
| 2016 Q1 | 91.67 Million SEK | -5.67% |
| 2016 FY | 88.9 Million SEK | -8.52% |
| 2016 Q3 | 88.49 Million SEK | -6.43% |
| 2015 Q4 | 97.18 Million SEK | -7.25% |
| 2015 FY | 97.18 Million SEK | -10.33% |
| 2015 Q1 | 110.64 Million SEK | 2.09% |
| 2015 Q3 | 104.77 Million SEK | -1.85% |
| 2015 Q2 | 106.74 Million SEK | -3.53% |
| 2014 Q1 | 89.27 Million SEK | 3.95% |
| 2014 Q2 | 96.56 Million SEK | 8.17% |
| 2014 Q4 | 108.37 Million SEK | 5.09% |
| 2014 FY | 108.37 Million SEK | 26.19% |
| 2014 Q3 | 103.12 Million SEK | 6.79% |
| 2013 Q2 | 88.76 Million SEK | 5.69% |
| 2013 Q3 | 87.54 Million SEK | -1.38% |
| 2013 FY | 85.88 Million SEK | 2.1% |
| 2013 Q4 | 85.88 Million SEK | -1.89% |
| 2013 Q1 | 83.98 Million SEK | -0.16% |
| 2012 Q4 | 84.11 Million SEK | -3.35% |
| 2012 Q1 | 86.7 Million SEK | -3.34% |
| 2012 Q2 | 90.39 Million SEK | 4.26% |
| 2012 FY | 84.11 Million SEK | -6.22% |
| 2012 Q3 | 87.03 Million SEK | -3.71% |
| 2011 Q2 | 86.18 Million SEK | -4.56% |
| 2011 FY | 89.69 Million SEK | -8.45% |
| 2011 Q3 | 88.18 Million SEK | 2.32% |
| 2011 Q4 | 89.69 Million SEK | 1.71% |
| 2011 Q1 | 90.29 Million SEK | -7.84% |
| 2010 Q4 | 97.97 Million SEK | -3.34% |
| 2010 Q3 | 101.36 Million SEK | -6.29% |
| 2010 Q2 | 108.16 Million SEK | 34.99% |
| 2010 FY | 97.97 Million SEK | 22.03% |
| 2010 Q1 | 80.13 Million SEK | -0.19% |
| 2009 Q4 | 80.28 Million SEK | 0.0% |
| 2009 FY | 80.28 Million SEK | -22.97% |
| 2008 FY | 104.22 Million SEK | 7.29% |
| 2007 FY | 97.14 Million SEK | 13.45% |
| 2006 FY | 85.62 Million SEK | -7.63% |
| 2005 FY | 92.69 Million SEK | 23.65% |
| 2004 FY | 74.96 Million SEK | -1.41% |
| 2003 FY | 76.03 Million SEK | 137.99% |
| 2002 FY | 31.95 Million SEK | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| AddLife AB (publ) | 1.65 Billion SEK | 73.563% |
| Bonesupport Holding AB (publ) | 83.3 Million SEK | -424.585% |
| Doxa AB (publ) | - SEK | -Infinity% |
| Elekta AB (publ) | 3.25 Billion SEK | 86.591% |
| iZafe Group AB (publ) | 4.05 Million SEK | -10684.8% |
| Ortivus AB (publ) | 12.45 Million SEK | -3407.505% |
| Ortivus AB (publ) | 12.45 Million SEK | -3407.505% |
| Q-linea AB (publ) | 46.52 Million SEK | -839.24% |
| S2Medical AB (publ) | 4.09 Million SEK | -10559.288% |
| Synsam AB (publ) | 707 Million SEK | 38.19% |